company background image
APEN logo

Apollo Endosurgery NasdaqGM:APEN Stock Report

Last Price

US$10.00

Market Cap

US$579.7m

7D

0.8%

1Y

67.8%

Updated

06 Apr, 2023

Data

Company Financials +

Apollo Endosurgery, Inc.

NasdaqGM:APEN Stock Report

Market Cap: US$579.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

APEN Stock Overview

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy.

APEN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Apollo Endosurgery, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Apollo Endosurgery
Historical stock prices
Current Share PriceUS$10.00
52 Week HighUS$10.30
52 Week LowUS$3.49
Beta2.32
1 Month Change0.50%
3 Month Change1.11%
1 Year Change67.79%
3 Year Change360.83%
5 Year Change70.94%
Change since IPO-17.76%

Recent News & Updates

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Nov 30
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Recent updates

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Nov 30
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?

Aug 05
Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?

Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings

Aug 04

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Mar 02
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?

Aug 04
Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?

Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy

Jun 28

Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?

May 05
Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?

Apollo Endosurgery EPS beats by $0.05, beats on revenue

May 04

A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)

Mar 24
A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)

What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?

Mar 03
What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?

Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares

Feb 10
Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares

We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt

Jan 31
We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt

Assessing Apollo Endosurgery

Dec 27

If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%

Dec 27
If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%

Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?

Dec 01
Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?

Apollo Endosurgery EPS beats by $0.10, beats on revenue

Nov 05

Shareholder Returns

APENUS Medical EquipmentUS Market
7D0.8%2.2%0.4%
1Y67.8%13.3%28.8%

Return vs Industry: APEN exceeded the US Medical Equipment industry which returned -13.3% over the past year.

Return vs Market: APEN exceeded the US Market which returned -11.4% over the past year.

Price Volatility

Is APEN's price volatile compared to industry and market?
APEN volatility
APEN Average Weekly Movement0.5%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: APEN has not had significant price volatility in the past 3 months.

Volatility Over Time: APEN's weekly volatility has decreased from 12% to 1% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005202Chas McKhannhttps://www.apolloendo.com

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands.

Apollo Endosurgery, Inc. Fundamentals Summary

How do Apollo Endosurgery's earnings and revenue compare to its market cap?
APEN fundamental statistics
Market capUS$579.72m
Earnings (TTM)-US$39.84m
Revenue (TTM)US$76.86m

7.5x

P/S Ratio

-14.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
APEN income statement (TTM)
RevenueUS$76.86m
Cost of RevenueUS$34.43m
Gross ProfitUS$42.43m
Other ExpensesUS$82.27m
Earnings-US$39.84m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.69
Gross Margin55.20%
Net Profit Margin-51.84%
Debt/Equity Ratio164.7%

How did APEN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.